BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/4/2017 8:16:34 AM | Browse: 430 | Download: 310
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 32821
Country/Territory United Kingdom
2017-01-26 21:02
Peer-Review Started
2017-01-28 20:11
To Make the First Decision
2017-03-06 18:01
Return for Revision
2017-03-08 08:56
2017-03-15 00:31
Second Decision
2017-04-12 18:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-04-24 10:34
Articles in Press
2017-04-24 10:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-04-28 10:03
Publish the Manuscript Online
2017-05-04 08:16
ISSN 2150-5349 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Frontier
Article Title 5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
Manuscript Source Invited Manuscript
All Author List Morris Gordon
Funding Agency and Grant Number
Corresponding author Dr. Morris Gordon, School of Medicine and Dentistry, University of Central Lancashire, University of Central Lancashire, HA118, Harrington Building, Preston PR1 2HE, United Kingdom. morris@betterprescribing.com
Keywords 5-Aminosalicylate; Systematic review; Crohn’s disease; Inflammatory bowel disease; Cochrane
Core Tip This paper proposes that the varying length of remission and disease activity of patients enrolled in studies for medically induced remission is different to surgical induced remission and may explain differences in findings. This guides future research proposals. Future primary research is needed in the medical induced remission setting which considers the length of remission on enrolment and endoscopic or histological disease scores. Additionally, secondary research to rank the various treatment options in the post-surgical setting could be achieved through the use of network meta-analysis.
Publish Date 2017-05-04 08:16
Citation Gordon M. 5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence. World J Gastrointest Pharmacol Ther 2017; 8(2): 99-102
Url http://www.wjgnet.com/2150-5349/full/v8/i2/99.htm
DOI http://dx.doi.org/10.4292/wjgpt.v8.i2.99
Full Article (PDF) WJGPT-8-99.pdf
Full Article (Word) WJGPT-8-99.doc
Manuscript File 32821-Review.doc
Answering Reviewers 32821-Answering reviewers.pdf
Audio Core Tip 32821-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 32821-Conflict-of-interest statement.pdf
Copyright License Agreement 32821-Copyright assignment.pdf
Peer-review Report 32821-Peer-review(s).pdf
Scientific Misconduct Check 32821-Scientific misconduct check.pdf
Scientific Editor Work List 32821-Scientific editor work list.pdf